[Recommendations for evaluation of interferon inducers of clinical importance].
D000818:Animals; D002460:Cell Line; D000882:Haplorhini; D066298:In Vitro Techniques; D007369:Interferon Inducers / Q000494:pharmacology* / Q000627:therapeutic use; D007372:Interferons / Q000096:biosynthesis*; D008253:Macaca mulatta; D051379:Mice; D009522:Newcastle disease virus / Q000472:pathogenicity; D009975:Orthomyxoviridae / Q000472:pathogenicity; D017955:Poliovirus / Q000472:pathogenicity; D011066:Poly C / Q000494:pharmacology; D011069:Poly I / Q000494:pharmacology; D011070:Poly I-C / Q000494:pharmacology; D011107:Polylysine / Q000494:pharmacology; D011749:Pyrogens / Q000494:pharmacology
D007369:Interferon Inducers; D011749:Pyrogens; D011107:Polylysine; D011069:Poly I; D011066:Poly C; D007372:Interferons; D011070:Poly I-C
Rekomendatsii po otsenke induktorov interferona klinicheskogo znacheniia.